Processa Pharmaceuticals Inc (NASDAQ: PCSA) Not A Good Play Anymore?
Processa Pharmaceuticals Inc (PCSA) concluded trading on Wednesday at a closing price of $0.26, with 9.21 million shares of worth about $2.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -80.32% during that period and on April 30, 2025 the price saw a […]
Processa Pharmaceuticals Inc (PCSA): Street Finally Waking Up
Currently, there are 5.27M common shares owned by the public and among those 4.67M shares have been available to trade. The company’s stock has a 5-day price change of -12.14% and -68.88% over the past three months. PCSA shares are trading -70.77% year to date (YTD), with the 12-month market performance down to -85.32% lower. […]
There Is Clear Momentum For Processa Pharmaceuticals Inc (NASDAQ: PCSA)
Processa Pharmaceuticals Inc (PCSA) concluded trading on Wednesday at a closing price of $0.30, with 50.61 million shares of worth about $15.18 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -78.10% during that period and on April 03, 2025 the price saw a […]
Processa Pharmaceuticals Inc (NASDAQ: PCSA) Is Getting Increasingly Hard To Ignore
Walleye Capital LLC recently announced the acquisition of new stake in Processa Pharmaceuticals Inc (NASDAQ:PCSA). The institutional investor has increased its shareholding in the Healthcare company by 14.36% to 0.42 million shares with purchase of 52640.0 shares. This fresh investment now brings its stake to 1.70% valued currently at $0.14 million. In addition, Geode Capital […]
